×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [10]
高能物理研究所 [9]
兰州大学 [4]
山东大学 [3]
厦门大学 [2]
西安交通大学 [2]
更多...
内容类型
期刊论文 [44]
学位论文 [2]
会议论文 [1]
发表日期
2020 [1]
2019 [1]
2018 [7]
2017 [9]
2016 [3]
2015 [5]
更多...
学科主题
Biochemist... [1]
Chemistry;... [1]
Demography [1]
Engineerin... [1]
Oncology [1]
Pharmacolo... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共47条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma
期刊论文
MEDICINE, 2020, 卷号: 99
作者:
Wang, Fangzheng
;
Jiang Chuner
;
Wang Lei
;
Yan Fengqin
;
Ye Zhimin
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/11/30
concurrent chemotherapy
induction chemotherapy
intensity-modulated radiotherapy
nasopharyngeal carcinoma
prognosis
toxicity
Enhanced expression of ten-eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P-glycoprotein expression
期刊论文
CANCER MEDICINE, 2019, 卷号: 8, 期号: 3, 页码: 990-1003
作者:
Wang, Chuanxu
;
Ye, Hua
;
Zhang, Lei
;
Cheng, Yayu
;
Xu, Shifeng
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/11
chemotherapy resistance
cholangiocarcinoma
gemcitabine
P-gp
TET1
Intelligent mos2 nanotheranostic for targeted and enzyme-/ph-/nir-responsive drug delivery to overcome cancer chemotherapy resistance guided by pet imaging
期刊论文
Acs applied materials & interfaces, 2018, 卷号: 10, 期号: 4, 页码: 4271-4284
作者:
Dong, Xinghua
;
Yin, Wenyan
;
Zhang, Xiao
;
Zhu, Shuang
;
He, Xiao
收藏
  |  
浏览/下载:68/0
  |  
提交时间:2019/04/23
Mos2 nanosheets
Surface modification
Targeting and p-gp inhibition
Controlled therapy
Theranostics
Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose
期刊论文
THERANOSTICS, 2018
作者:
Lintao Cai
;
Zhenyu Luo
;
Hao Tian
;
Lanlan Liu
;
Zhikuan Chen
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2019/01/31
Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer
期刊论文
JOURNAL OF BUON, 2018, 卷号: 23, 期号: 5
作者:
Duan, Jianchun
;
Yang, Zhenhua
;
Liu, Dingyuan
;
Zhang, Zhen
;
Shi, Yunfei
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/04
advanced non-small cell lung cancer
bevacizumab
survival rate
clinical effect
GP chemotherapy
pH-Sensitive Poly(beta-amino ester)s Nanocarriers Facilitate the Inhibition of Drug Resistance in Breast Cancer Cells
期刊论文
NANOMATERIALS, 2018, 卷号: 8, 期号: 11, 页码: 952
作者:
Zhou MX(周梦雪)
;
Xie J(谢进)
;
Qi RX(齐荣翔)
;
Lu HR(卢会茹)
;
Chen J(陈俊)
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/10/11
nanoparticles
pH responsive
poly(beta-amino ester)s
doxorubicin
multidrug resistance
Intelligent MoS2 Nanotheranostic for Targeted and Enzyme-/pH-/NIR-Responsive Drug Delivery To Overcome Cancer Chemotherapy Resistance Guided by PET Imaging
期刊论文
ACS APPLIED MATERIALS & INTERFACES, 2018, 卷号: 10, 期号: 4, 页码: 4271-4284
作者:
Zhu, S
;
He, X
;
Yu, J
;
Xie, JN
;
Guo, Z
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/09/24
MoS2 nanosheets
surface modification
targeting and P-gp inhibition
controlled therapy
theranostics
Intelligent MoS2 Nanotheranostic for Targeted and Enzyme-/pH-/NIR-Responsive Drug Delivery To Overcome Cancer Chemotherapy Resistance Guided by PET Imaging
期刊论文
ACS APPLIED MATERIALS & INTERFACES, 2018, 卷号: 10, 期号: 4, 页码: 4271-4284
作者:
Dong, Xinghua
;
Yin, Wenyan
;
Zhang, Xiao
;
Zhu, Shuang
;
He, Xiao
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/11
MoS2 nanosheets
surface modification
targeting and P-gp inhibition
controlled therapy
theranostics
Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer
期刊论文
2018, 卷号: 23, 期号: 5, 页码: 1402-1406
作者:
Duan, Jianchun
;
Yang, Zhenhua
;
Liu, Dingyuan
;
Zhang, Zhen
;
Shi, Yunfei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
advanced non-small cell lung cancer
bevacizumab
survival rate
clinical effect
GP chemotherapy
BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe
期刊论文
CANCER LETTERS, 2017, 卷号: 402, 页码: 81-92
作者:
Bai, Zhaoshi
;
Gao, Meiqi
;
Zhang, Huijuan
;
Guan, Qi
;
Xu, Jingwen
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2017/10/29
Cbsis
Multidrug Resistance
P-glycoprotein
Apoptosis-resistance
Mitotic Catastrophe
©版权所有 ©2017 CSpace - Powered by
CSpace